title: Treatment with the angiotensin II antagonist valsartan in patients with chronic renal failure and hypertension.
authors.affiliation: Department of Nephrology and Rheumatology, Heinrich-Heine-University, Düsseldorf, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Plum
authors.forename: B
authors.initials: B
authors.lastname: Bünten
authors.forename: R
authors.initials: R
authors.lastname: Németh
authors.forename: B
authors.initials: B
authors.lastname: Grabensee
mesh_terms: D000368:Aged; D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007676:Kidney Failure, Chronic / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012079:Renal Circulation / Q000187:drug effects; D013777:Tetrazoles / Q000627:therapeutic use*; D014633:Valine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000068756:Valsartan
chemical_list: D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D013777:Tetrazoles; D000068756:Valsartan; D014633:Valine